Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 Study of TS-091 (enerisant) in Patients With Narcolepsy
jRCT2080222479Phase 2Completed
- Sponsor
- Taisho Pharmaceutical
- Start
- May 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in narcolepsy comparing TS-091 (enerisant) with Placebo (2 arms). Started May 2014; status: completed.
02
Drugs
Enerisant
03
Conditions
narcolepsy
Beyond the preview
Go deeper on jRCT2080222479.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222479.